More
    Guided Solutions - Connecting Talent With Innovation/div>

    CVRx has more data supporting long-term benefits of Barostim

    CVRx announced the publication of post-market data highlighting long-term, sustained benefits with its Barostim device.Minneapolis-based CVRx published results from the BeAT-HF trial in the...

    QT imaging’s breast imaging system proves as effective as mammography

    Medical device company QT Imaging Holdings has announced positive data demonstrating that its Breast Acoustic CT scan imaging technique can be used as a...

    Sight Sciences touts eye pressure reduction with glaucoma OMNI device

    US-based Sight Sciences has published the two-year post-surgical outcomes of its minimally invasive glaucoma surgery device, the OMNI surgical system. The data from the real-world...

    Signati kicks off trial investigating quicker vasectomy device

    Signati Medical has enrolled the first patient in a clinical trial investigating its device designed to quicken vasectomy procedures. The trial, operating under an investigative...

    Photopharmics kickstarts phototherapy trial for Parkinson’s disease 

    US-based equipment manufacturer Photopharmics has announced the initiation of its ‘Celeste light for PD’ clinical trial investigating the Celeste phototherapy device.  The US Food and...

    Novocure’s TTFields device slows metastasis in NSCLC

    NovoCure’s Tumor Treating Fields (TTFields) therapy met its primary endpoint in the Phase III METIS trial by slowing the progression of brain metastasis in...

    Cleerly touts new data for AI cardiovascular software

    Digital healthcare company Cleerly has announced that positive data from two studies investigating its AI-QCT ISCHEMIA software device has been published.  Cleerly’s ISCHEMIA software device...

    Nyxoah’s nerve stimulation device meets endpoints in sleep apnoea study

    Nyxoah’s hypoglossal nerve stimulation system, Genio, met the co-primary endpoints at 12 months in the pivotal DREAM trial in adults with obstructive sleep apnoea...

    Spineart completes BAGUERA C IDE trial enrollment in US

    Spineart has successfully completed patient enrollment in its pivotal US investigational device exemption (IDE) trial for the BAGUERA C cervical disc prosthesis. The BAGUERA C...

    Latest articles